You have 9 free searches left this month | for more free features.

Astrocytoma

Showing 1 - 25 of 748

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Astrocytoma, Glioblastoma Trial in Spain, United States (CC-90010)

Active, not recruiting
  • Astrocytoma
  • Glioblastoma
  • Jacksonville, Florida
  • +8 more
Dec 14, 2022

Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

Recruiting
  • Malignant Glioma of Brain
  • +8 more
  • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
  • Detroit, Michigan
    Henry Ford Health System
Jan 9, 2023

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    Grade III Astrocytoma, Grade IV Astrocytoma, Astrocytoma, Grade IV Trial in Saint Louis (Tadalafil)

    Active, not recruiting
    • Grade III Astrocytoma
    • +3 more
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jun 9, 2022

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

    Recruiting
    • Glioblastoma Multiforme
    • +2 more
    • Birmingham, Alabama
      University of Alabama at Birmingham
    Jan 30, 2023

    Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

    Recruiting
    • Glioblastoma
    • +3 more
    • Adaptive Radiotherapy
    • New York, New York
      Columbia University Irving Medical Center
    Oct 27, 2023

    Compliance, Patient, Glioblastoma, Astrocytoma, Grade IV Trial (Psychological intervention)

    Not yet recruiting
    • Compliance, Patient
    • +2 more
    • Psychological intervention
    • (no location specified)
    Aug 23, 2023

    Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult Trial (NEO212 Oral Capsule, Ipilimumab,

    Not yet recruiting
    • Diffuse Astrocytoma, IDH-Mutant
    • +20 more
    • NEO212 Oral Capsule
    • +8 more
    • (no location specified)
    Sep 18, 2023

    Glioma, Pilocytic Astrocytoma, Pilomyxoid Astrocytoma Trial in Rochester, Memphis (Hippocampal-avoidance proton therapy)

    Recruiting
    • Glioma
    • +6 more
    • Hippocampal-avoidance proton therapy
    • Rochester, Minnesota
    • +1 more
    Aug 18, 2022

    Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in Duarte, Chicago (Neural stem cells loaded with an

    Completed
    • Glioma
    • +7 more
    • Neural stem cells loaded with an oncolytic adenovirus
    • Duarte, California
    • +1 more
    Dec 28, 2022

    Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)

    Recruiting
    • Glioblastoma Multiforme
    • Anaplastic Astrocytoma
    • New York, New York
      Lenox Hill Brain Tumor Center
    Nov 10, 2022

    Glioblastoma, Astrocytoma, Venous Thromboembolism Trial (Apixaban)

    Not yet recruiting
    • Glioblastoma
    • +2 more
    • (no location specified)
    Jan 4, 2023

    IDH Family Wildtype, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma Trial in Houston (Laser Interstitial Thermal

    Terminated
    • IDH Family Wildtype
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 14, 2022

    Vascular Habitats Within Astrocytoma Grade 4 at Molecular,

    Recruiting
    • Astrocytoma, Grade IV
    • +7 more
      • Valencia, Spain
        Biomedical Data Science Lab. Universitat Politècnica de València
      May 11, 2022

      Astrocytoma, Glioblastoma, Oligodendroglioma Trial in Atlanta (Craniotomy, Quantitative Oblique Back-Illumination Microscopy)

      Not yet recruiting
      • Astrocytoma
      • +2 more
      • Craniotomy
      • Quantitative Oblique Back-Illumination Microscopy
      • Atlanta, Georgia
        Emory University Hospital/Winship Cancer Institute
      Aug 22, 2022

      Astrocytoma, IDH-Mutant, Grade 2, Astrocytoma, IDH-Mutant, Grade 3 Trial in United States (other, radiation, drug)

      Active, not recruiting
      • Astrocytoma, IDH-Mutant, Grade 2
      • Astrocytoma, IDH-Mutant, Grade 3
      • Questionnaire Administration
      • +3 more
      • Phoenix, Arizona
      • +24 more
      Dec 7, 2022

      Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme Trial run by the NCI (Radiation)

      Active, not recruiting
      • Astrocytoma, Grade IV
      • +3 more
      • Radiation
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 26, 2023

      Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

      Not yet recruiting
      • Recurrent High Grade Glioma
      • +4 more
      • (no location specified)
      Jan 24, 2023

      Supramaximal Resection Versus Maximal Resection for High-Grade

      Recruiting
      • Glioblastoma
      • +11 more
      • Supramaximal resection
      • Maximal safe resection
      • San Francisco, California
      • +7 more
      Nov 1, 2023

      Astrocytoma, Grades II, III and IV, Glioblastoma Multiforme, Giant Cell Glioblastoma Trial run by the National Cancer Institute

      Recruiting
      • Astrocytoma, Grades II, III and IV
      • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 31, 2023

      Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)

      Not yet recruiting
      • Glioblastoma Multiforme
      • +4 more
      • SIACI of cetuximab and bevacizumab
      • Miami, Florida
        Jackson Memorial Hospital
      Jul 14, 2023

      Glioblastoma Trial in Belgium, Germany, Netherlands (CV09050101 mRNA vaccine (CVGBM) 12 µg, CV09050101 mRNA vaccine (CVGBM) 25

      Recruiting
      • Glioblastoma
      • CV09050101 mRNA vaccine (CVGBM) 12 μg
      • +5 more
      • Woluwe-Saint-Lambert, Brussels, Belgium
      • +14 more
      Jul 12, 2023

      Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial

      Recruiting
      • Glioblastoma
      • +8 more
      • Intra-arterial Cetuximab
      • +2 more
      • New York, New York
        Lenox Hill Brain Tumor Center
      Oct 17, 2022

      Adult Diffuse Glioma Based on Deep Learning

      Recruiting
      • Astrocytoma
      • +2 more
      • multi-parametric magnetic resonance imaging scan
      • Pathology examination
      • Nanjing, Jiangsu, China
        Department of Radiology, the Affiliated Drum Tower Hospital of N
      Nov 21, 2022

      Glioblastoma, Astrocytoma, Oligodendroglioma Trial (OKN-007)

      Withdrawn
      • Glioblastoma
      • +2 more
      • (no location specified)
      Oct 5, 2022